GET DAILY SIGNALSWhy Is Quantum-Si (QSI) Stock Down -6.57% Today?
Key Takeaways
- QSI shares fell 6.57% to $1.28, giving back a portion of last week's sharp gains.
- The decline was driven primarily by profit-taking following a volatile multi-session rebound, rather than a single new corporate announcement.
- A lingering post-earnings hangover from mixed third-quarter results and a delayed commercial launch continued to weigh on sentiment.
- The move reflects a broader risk-off tone across speculative, high-beta small-cap life-sciences names.
- Traders are watching the company's Proteus platform timeline, cash runway, and any fresh analyst commentary.
- For additional context, explore Price Targets, Earnings, and Forecast pages for this ticker.
- To see how AI-powered strategies are trading this and other names right now, visit Trending AI Robots.
Opening Summary
Quantum-Si Incorporated (QSI), a Branford, Connecticut-based life-sciences company developing single-molecule protein sequencing technology, saw its shares fall 6.57% during Tuesday's session. The stock traded at $1.28, down $0.09 from the prior session's closing price of $1.37. The decline marked a pullback after a sharp, two-session rebound that had lifted the shares roughly 17% from their post-earnings low. Market participants attributed the move largely to profit-taking and renewed caution around the company's near-term commercial trajectory.
Profit-Taking After a Volatile Rebound
The stock's decline followed a pronounced burst of upside momentum. After tumbling on mixed third-quarter results, QSI rallied 13.68% on November 6 and added another 3.01% on November 9. Such rapid, high-beta swings are characteristic of speculative small-cap names, and Tuesday's session appeared to reflect traders locking in gains from that rebound rather than responding to any new company-specific disclosure. The pullback underscores how sensitive QSI remains to short-term momentum and sentiment flows.
Post-Earnings Hangover: Revenue Miss and Proteus Delay
Beneath the day-to-day volatility, investors are still digesting the company's November 5 third-quarter report. Quantum-Si posted a GAAP loss of $0.10 per share, narrower than the $0.12 consensus estimate, but revenue of roughly $210,000 came in below the approximately $280,000 analysts had projected. Management also outlined a shift of its next-generation Proteus platform's commercial launch into the second quarter of 2027, while targeting about $12 million in annual operating-expense savings. The revenue shortfall and the extended launch timeline have kept a cloud over the stock, giving traders a reason to sell into strength even as headline EPS improved.
Market Context and Trading Activity
The move unfolded amid a broader risk-off tone in speculative life-sciences and sequencing names, where unprofitable, early-stage companies tend to underperform when investors rotate toward more defensive positioning. Trading in QSI remained elevated relative to historical norms, consistent with the stock's recent pattern of heavy volume and wide intraday ranges. The shares remain well below their 52-week high and continue to trade with a beta and volatility profile far above the broader market, making technical support and resistance levels less reliable than they would be for a larger, more liquid name.
What Comes Next for QSI
Looking ahead, investors will focus on the Proteus launch timeline, the company's ability to convert its technology pipeline into meaningful revenue, and its cash position as it funds continued commercialization. Insider selling activity and elevated short interest remain points of scrutiny. Broader conditions in biotech and life-sciences tools, along with overall risk appetite, are likely to continue influencing day-to-day moves. Because the company remains pre-profitability, sentiment and momentum can outweigh fundamentals over short periods, keeping two-sided volatility elevated. Risks include further commercialization delays, weaker-than-expected adoption of its instruments, and potential future capital needs.
Trending AI Robots
Tickeron offers hundreds of AI-powered trading bots that monitor thousands of tickers, but only the strongest performers under current market conditions are showcased in its curated Trending AI Robots section. These bots vary by strategy, timeframe, performance metrics, and the symbols they trade, allowing users to explore a range of automated approaches. Traders seeking data-driven insights into names like QSI may find this section a useful starting point for further research.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.
QSI's Stochastic Oscillator is remaining in oversold zone for 3 days
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Technical Analysis (Indicators)
Bullish Trend Analysis
The 50-day moving average for QSI moved above the 200-day moving average on October 23, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +17.09% 3-day Advance, the price is estimated to grow further. Considering data from situations where QSI advanced for three days, in 160 of 199 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
The Aroon Indicator entered an Uptrend today. In 96 of 122 cases where QSI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 79%.
Bearish Trend Analysis
The 10-day RSI Indicator for QSI moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In 23 of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at 88%.
The Momentum Indicator moved below the 0 level on November 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on QSI as a result. In 84 of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for QSI turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 41 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where QSI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
QSI broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. QSI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 91 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.616) is normal, around the industry mean (4.142). P/E Ratio (-2.891) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (100.000) is also within normal values, averaging (40.124).
The Tickeron PE Growth Rating for this company is 94 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QSI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
How is a Will Implemented After my Death?
What is a foreign institutional investor?
How can one use ADX as the leading tool to evaluate the strength of a trend?
Best Meat Company Stocks to Buy with Tickeron: A Comprehensive Analysis
[Test] Automate Your Success: Explore Tickeron's Top 10 Stock Trading Robots Now!
General Information
Industry MedicalNursingServices
Advertisement